biomedicina slovenica


pr=Cuschieri : 16

  1. Vink Frederique J.; Meijer Chris J.L.M.; Hesselink Albertus; Floore Arno N.; Lissenberg-Witte Birgit I.; Bonde Jesper; Pedersen Helle; Cuschieri Kate S.; Poljak Mario; Oštrbenk Valenčak Anja
    FAM19A4/miR124-2 methylation testing and HPV16/18 genotyping in HPV-positive women under the age of 30 years
    2022
  2. Poljak Mario; Cuschieri Kate S.; Waheed Dur-E-Nayab; Baay Marc; Vorsters Alex
    Impact of the COVID-19 pandemic on human papillomavirus‐based testing services to support cervical cancer screening
    2021
  3. Arbyn Marc; Simon Marie; Peeters Eliana; Xu Lan; Meijer Chris J.L.M.; Berkhof Johannes; Cuschieri Kate S.; Bonde Jesper; Oštrbenk Valenčak Anja; Poljak Mario
    2020 list of human papillomavirus assays suitable for primary cervical cancer screening
    2021
  4. Calero Valdez André; Iftekhar Emil Nafis; Oliu-Barton Miquel; Böhm Robert; Cuschieri Sarah; Czypionka Thomas; Dumpis Uga; Giordano Giulia; Hanson Claudia; Hel Zdenek; Perc Matjaž
    Europe must come together to confront omicron
    2022
  5. Meijer C. J. L. M.; Hesselink B.; Heideman D. A. M.; Petry K. U.; Poljak Mario; Bonde J.; Cuschieri Kate S.; Del Pino M; Quint Wim; Floore A.
    Surveillance of young HPV-positive women below age of 30 by FAM19A4/MIR124 methylation
    2020
  6. Xu Lan; Benoy Ina; Cuschieri Kate S.; Poljak Mario; Bonde Jesper; Arbyn Marc
    Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions
    2019
  7. Hesselink B.; Petry Karl Ulrich; Cuschieri Kate S.; Bonde J.; Del Pino M; Quint Wim; Poljak Mario; Meijer C. J. L. M.; Floore A.; Heideman D. A. M.
    Surveillance of young HPV-positive women below age of 30 by FAM19A4/miR124methylation
    2019
  8. Viti Jessica; Poljak Mario; Oštrbenk Anja; Bhatia Ramya; Alcañiz Boada Elia; Cornall Alyssa M.; Cuschieri Kate S.; Garland Suzanne; Xu Lan; Arbyn Marc
    Validation of EUROArray HPV test using the VALGENT framework
    2018
  9. Cornall A. M.; Viti J.; Poljak Mario; Oštrbenk Anja; Bhatia R.; Alca niz Boada E.; Cuschieri Kate S.; Garland S.; Xu Lan; Arbyn Marc
    Validation of EUROarray HPV test using the VALGENT framework
    2018
  10. Poljak Mario; Carozzi Francesca; Cuschieri Kate S.
    Quality assurance programs for HPV - based cervical cancer screening and the implication for labora tory organization
    2017
  11. Poljak Mario; Rogovskaya Svetlana; Seme Katja; Maver Vodičar Polona; Kocjan Boštjan; Cuschieri Kate S.; Arbyn Marc; Syrjänen Stina
    Cervical cancer & cytology based screening programs in Eastern and Central European countries
    2012
  12. Abryn M.; Poljak Mario; Mejjer C.; Cuschieri Kate S.; Heard Isabelle; Bogers Johannes; Bonde J.; Tommasino M.; Ifner T.; Sasieni P.
    Update of the list of HPV assays that fulfill requirements for primary cervical cancer screening
    2017
  13. Arbyn Marc; Depuydt Christophe; Benoy Ina; Bogers Johannes; Cuschieri Kate S.; Schmitt Markus; Pawlita Michael; Geraets Daan; Heard Isabelle; Poljak Mario
    VALGENT
    2016
  14. Arbyn Marc; Snijders P.J.F.; Meijer C. J. L. M.; Berkhof Johannes; Cuschieri Kate S.; Kocjan Boštjan; Poljak Mario
    Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
    2015
  15. Poljak Mario; Seme Katja; Maver Vodičar Polona; Kocjan Boštjan; Cuschieri Kate S.; Rogovskaya Svetlana; Arbyn Marc; Syrjänen Stina
    Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe
    2013
  16. Campell PA; Cuschieri A; Liović Mirjana; Lane FB
    Cytoskeleton elasticity and dynamics during cell motility: AFM observation of PtK2 cells in the pico-newton force regime
    2001


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics